(Q53555247)

15 May 2018

title

Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial. (English)

1 reference

15 May 2018

main subject

cell line

0 references

phase II clinical trial

0 references

1 reference

1 reference

Socinski MA

1

1 reference

15 May 2018

Steagall A

series ordinal

2

1 reference

15 May 2018

Gillenwater H

series ordinal

3

1 reference

15 May 2018

publication date

1 January 1999

1 reference

15 May 2018

published in

Cancer Investigation

1 reference

15 May 2018

volume

17

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

181-188

1 reference

15 May 2018

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Chemotherapy of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909909021419

10.3109/07357909909021419

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018